Benitec has appointed CEO Sue MacLeman to its board of directors as managing director.
MacLeman joined Benitec late last year. Before that, she was CEO of Australian biotech firm EqiTx.
She holds a BS in pharmacology from the University of Queensland.
Intellect Neurosciences has appointed William Keane to its board of directors.
Keane, who served as CFO and corporate secretary at antisense firm Genta until 2005, is currently a consultant, Intellect said.
He holds an MBA from Rutgers University School of Management and a BA in microbiology from Rutgers College.